These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 2413022

  • 1. Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin.
    Salonen EM, Saksela O, Vartio T, Vaheri A, Nielsen LS, Zeuthen J.
    J Biol Chem; 1985 Oct 05; 260(22):12302-7. PubMed ID: 2413022
    [Abstract] [Full Text] [Related]

  • 2. The extracellular matrix proteins laminin and fibronectin contain binding domains for human plasminogen and tissue plasminogen activator.
    Moser TL, Enghild JJ, Pizzo SV, Stack MS.
    J Biol Chem; 1993 Sep 05; 268(25):18917-23. PubMed ID: 8360181
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.
    Stewart RJ, Fredenburgh JC, Weitz JI.
    J Biol Chem; 1998 Jul 17; 273(29):18292-9. PubMed ID: 9660794
    [Abstract] [Full Text] [Related]

  • 4. Degradation of human plasma and extracellular matrix fibronectin by tissue type plasminogen activator and urokinase.
    Marchina E, Barlati S.
    Int J Biochem Cell Biol; 1996 Oct 17; 28(10):1141-50. PubMed ID: 8930138
    [Abstract] [Full Text] [Related]

  • 5. Modulation of tissue plasminogen activator-catalyzed plasminogen activation by synthetic peptides derived from the amino-terminal heparin binding domain of fibronectin.
    Stack MS, Pizzo SV.
    J Biol Chem; 1993 Sep 05; 268(25):18924-8. PubMed ID: 8360182
    [Abstract] [Full Text] [Related]

  • 6. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE, Smith CJ.
    Arch Biochem Biophys; 1993 Nov 15; 307(1):138-45. PubMed ID: 8239651
    [Abstract] [Full Text] [Related]

  • 7. Analysis of the binding of pro-urokinase and urokinase-plasminogen activator inhibitor-1 complex to the low density lipoprotein receptor-related protein using a Fab fragment selected from a phage-displayed Fab library.
    Horn IR, Moestrup SK, van den Berg BM, Pannekoek H, Nielsen MS, van Zonneveld AJ.
    J Biol Chem; 1995 May 19; 270(20):11770-5. PubMed ID: 7538122
    [Abstract] [Full Text] [Related]

  • 8. Characterization of a fusion protein consisting of amino acids 1 to 263 of tissue-type plasminogen activator and amino acids 144 to 411 of urokinase-type plasminogen activator.
    Nelles L, Lijnen HR, Collen D, Holmes WE.
    J Biol Chem; 1987 Aug 05; 262(22):10855-62. PubMed ID: 2956260
    [Abstract] [Full Text] [Related]

  • 9. Binding of tissue-type plasminogen activator to fibrinogen fragments.
    Bosma PJ, Rijken DC, Nieuwenhuizen W.
    Eur J Biochem; 1988 Mar 01; 172(2):399-404. PubMed ID: 3127207
    [Abstract] [Full Text] [Related]

  • 10. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
    Lijnen HR, Nelles L, Van Hoef B, Demarsin E, Collen D.
    J Biol Chem; 1988 Dec 15; 263(35):19083-91. PubMed ID: 3143723
    [Abstract] [Full Text] [Related]

  • 11. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H.
    J Clin Invest; 1989 Aug 15; 84(2):647-55. PubMed ID: 2503541
    [Abstract] [Full Text] [Related]

  • 12. Conversion of Glu-plasminogen to Lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface.
    Gong Y, Kim SO, Felez J, Grella DK, Castellino FJ, Miles LA.
    J Biol Chem; 2001 Jun 01; 276(22):19078-83. PubMed ID: 11264290
    [Abstract] [Full Text] [Related]

  • 13. Fibronectin decreases the stimulatory effect of fibrin and fibrinogen fragment FCB-2 on plasmin formation by tissue plasminogen activator.
    Beckmann R, Geiger M, de Vries C, Pannekoek H, Binder BR.
    J Biol Chem; 1991 Feb 05; 266(4):2227-32. PubMed ID: 1824940
    [Abstract] [Full Text] [Related]

  • 14. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase.
    Hajjar KA, Hamel NM.
    J Biol Chem; 1990 Feb 15; 265(5):2908-16. PubMed ID: 2154465
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of fibrin binding on the biochemical properties of single-chain tissue-type plasminogen activator (t-PA) and single-chain chimeric plasminogen activator (t-PA/scu-PA).
    Fischer BE.
    Blood Coagul Fibrinolysis; 1992 Feb 15; 3(1):39-46. PubMed ID: 1320415
    [Abstract] [Full Text] [Related]

  • 16. Substrate specificity of tissue-type and urokinase-type plasminogen activators.
    Rijken DC, Groeneveld E.
    Biochem Biophys Res Commun; 1991 Jan 31; 174(2):432-8. PubMed ID: 1899564
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
    Pannell R, Black J, Gurewich V.
    J Clin Invest; 1988 Mar 31; 81(3):853-9. PubMed ID: 2963831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.